advertisement
Fujita K 9
Showing records 1 to 9 | Display all abstracts from Fujita K95001 Polypharmacy-associated potential contraindications of drug prescriptions in patients with primary angle closure disease in a real-world setting
Tanaka F
Journal of pharmaceutical health care and sciences 2021; 7: 17
95422 Impact of low luminance conditions on quality of life for the visually impaired: development of the Low Luminance Questionnaire Japanese version
Fujita K; Suzukamo Y
Japanese Journal of Ophthalmology 2021; 65: 554-560
95001 Polypharmacy-associated potential contraindications of drug prescriptions in patients with primary angle closure disease in a real-world setting
Shibatani N
Journal of pharmaceutical health care and sciences 2021; 7: 17
95422 Impact of low luminance conditions on quality of life for the visually impaired: development of the Low Luminance Questionnaire Japanese version
Murotani K
Japanese Journal of Ophthalmology 2021; 65: 554-560
95001 Polypharmacy-associated potential contraindications of drug prescriptions in patients with primary angle closure disease in a real-world setting
Fujita K; Ikesue H
Journal of pharmaceutical health care and sciences 2021; 7: 17
95422 Impact of low luminance conditions on quality of life for the visually impaired: development of the Low Luminance Questionnaire Japanese version
Jinno A
Japanese Journal of Ophthalmology 2021; 65: 554-560
95001 Polypharmacy-associated potential contraindications of drug prescriptions in patients with primary angle closure disease in a real-world setting
Yoshimizu S
Journal of pharmaceutical health care and sciences 2021; 7: 17
95422 Impact of low luminance conditions on quality of life for the visually impaired: development of the Low Luminance Questionnaire Japanese version
Kamei M
Japanese Journal of Ophthalmology 2021; 65: 554-560
95001 Polypharmacy-associated potential contraindications of drug prescriptions in patients with primary angle closure disease in a real-world setting
Muroi N; Kurimoto Y; Hashida T
Journal of pharmaceutical health care and sciences 2021; 7: 17
